Keya Medical

Keya Medical An international medical technology company developing deep learning-based medical devices. The AI CT FFR is FDA-cleared, CE-marked, and NMPA-approved.

Keya Medical is an international medical technology company developing deep learning-based medical devices for disease diagnosis and treatment. The company is committed to creating solutions that deliver clinical value at all stages in the patient care process, covering specialties including cardiology, neurology, pulmonology, pathology, and surgery. Keya Medical has four centers of excellence in Beijing, Shanghai, Shenzhen, and Seattle. The deep-learning-based CT FFR analysis DEEPVESSEL FFR is the company's flagship product. DEEPVESSEL FFR is a software medical device that uses deep learning technology to perform a non-invasive physiological functional assessment of the coronary arteries using coronary computed tomography angiography (CCTA).

Thanks to Calantic™ Digital Solutions, we can share the first  Bayer AI Imaging TechTalk between Mary-Pierre Waiss (Keya...
06/20/2025

Thanks to Calantic™ Digital Solutions, we can share the first Bayer AI Imaging TechTalk between Mary-Pierre Waiss (Keya Medical) and Michael Claytor (Bayer) about DeepVessel FFR, a noninvasive, AI-powered CT analysis tool for coronary artery disease.

DeepVessel FFR — a deep learning-driven CT analysis — brings catheter‑lab precision to the CT suite, enabling non-invasive fractional flow reserve (FFR) assessment right from CCTA.

✅ Interactive 3D heart model and PDF report

✅ Instant physiological insights

✅ Fully reimbursed (CPT 75580)

✅ Integrated into Bayer’s Calantic platform

Watch "Bringing Cath-Lab Precision to the CT Suite: A Conversation on DeepVessel FFR". Bayer AI Imaging TechTalk: Speaking with Keya Medical.

Join us this Thursday, March 20 | 12 PM – 1 PM EST for a FREE sponsored webinar on AI-Derived Decision-Making and Assess...
03/18/2025

Join us this Thursday, March 20 | 12 PM – 1 PM EST for a FREE sponsored webinar on AI-Derived Decision-Making and Assessment in Coronary Artery Disease (CAD).

**AI-derived decision-making and assessment in CAD** Join us for a FREE online webinar featuring Armin Zadeh, MD, MSCCT; Michael Blaha, MD, MPH; Dinesh Kalra, MD, FSCCT and Irfan Shafique, MD discussing DeepVessel FFRCT, AI plaque analysis, and biomarkers in risk stratification, diagnosis, predictin...

FREE SCCT Webinar sponsored by Keya Medical – AI in CAD Assessment & Decision-MakingJoin us for an insightful SCCT webin...
03/12/2025

FREE SCCT Webinar sponsored by Keya Medical – AI in CAD Assessment & Decision-Making

Join us for an insightful SCCT webinar exploring the role of AI-derived decision-making and assessment in CAD, featuring expert discussions on DeepVessel FFRCT, AI plaque analysis, and biomarkers for risk stratification, diagnosis, and predicting acute coronary syndrome.

🗓 Thursday, March 20
⏰ 12:00 PM – 1:00 PM EST
💻 Virtual | FREE to attend
Register now: https://scct.org/events/EventDetails.aspx?id=1941719&group=&_zs=3CKFd&_zl=HaSQ4

Speakers & Panelists:
Irfan Shafique, MD (Moderator)
Armin Zadeh, MD, MSCCT
Michael Blaha, MD, MPH
Dinesh Kalra, MD, FSCCT

AI in Cardiac Diagnostics: Moving Beyond Standard Coronary Anatomical AssessmentAt   in Amsterdam, Dr. Irfan Shafique in...
03/06/2025

AI in Cardiac Diagnostics: Moving Beyond Standard Coronary Anatomical Assessment

At in Amsterdam, Dr. Irfan Shafique introduced DEEPVESSEL FFR, Keya Medical's AI-driven CT-FFR solution designed to enhance non-invasive cardiac diagnostics.

In his presentation, "AI in CTFFR Analysis," Dr. Shafique showcased study cases demonstrating how DeepVessel FFR leverages deep learning to go beyond standard coronary anatomical assessment—delivering advanced physiological insights that support more precise, efficient, and patient-centered cardiovascular care.

At SCCT Global 2025, Dr. Shafique introduced DEEPVESSEL FFR, Keya Medical's AI-CT FFR designed to enhance non-invasive cardiac diagnostics.

08/19/2024

Advances in heart imaging and cardiovascular care. Learn how AI, including Keya Medical's CT FFR analysis DeepVessel FFR, makes diagnosis and treatment more precise. Check out the latest article in Radiology Today Magazine for more details.

Radiology Today newsmagazine reaches 40,000 radiology professionals nationwide on a monthly basis, covering areas such as Radiology Management, Bone Densitometry, Mammography, MRI, PACS, CT, Sonography, Nuclear Medicine, Radiation Oncology, Radiation Therapy, contrast agents, and more!

Learn about the latest in Keya Medical’s FFR CT analysis in our new blog, “DEEPVESSEL FFR CT-Recent Peer-Reviewed Public...
07/11/2024

Learn about the latest in Keya Medical’s FFR CT analysis in our new blog, “DEEPVESSEL FFR CT-Recent Peer-Reviewed Publications.” Discover how the deep learning-based DEEPVESSEL FFR is used in recent studies and how you can implement this accurate and economical solution into your workflow. Read more at https://www.keyamedical.com/deepvessel-ffr-ct-publications.

Following is a sampling of recent peer-reviewed publications and more studies with DEEPVESSEL FFR CT are in progress.

Address

107 Spring Street
Seattle, WA
98104

Alerts

Be the first to know and let us send you an email when Keya Medical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Keya Medical:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram